Nathan Weinstein
Stock Analyst at Aegis Capital
(0.16)
# 4,400
Out of 5,180 analysts
59
Total ratings
9.3%
Success rate
-33.07%
Average return
Main Sectors:
Stocks Rated by Nathan Weinstein
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| EVGN Evogene | Maintains: Buy | $100 → $80 | $0.77 | +10,289.61% | 2 | Sep 12, 2022 | |
| DRIO DarioHealth | Maintains: Buy | $400 → $300 | $8.02 | +3,640.65% | 6 | Aug 18, 2022 | |
| VNRX VolitionRx | Maintains: Buy | $9 → $6 | $0.20 | +2,870.30% | 5 | Aug 15, 2022 | |
| IMUX Immunic | Maintains: Buy | $40 → $35 | $1.11 | +3,053.15% | 2 | Aug 8, 2022 | |
| STXS Stereotaxis | Initiates: Buy | $6 | $1.84 | +226.09% | 1 | Jul 12, 2022 | |
| ORMP Oramed Pharmaceuticals | Maintains: Buy | $35 → $30 | $3.42 | +777.19% | 5 | May 16, 2022 | |
| TRVI Trevi Therapeutics | Initiates: Buy | $10 | $11.93 | -16.18% | 1 | Mar 29, 2022 | |
| MDWD MediWound | Maintains: Buy | $63 → $49 | $16.11 | +204.16% | 4 | Mar 21, 2022 | |
| ENVB Enveric Biosciences | Downgrades: Hold | $63,000 → $1,800 | $1.94 | +92,683.51% | 2 | Mar 8, 2022 | |
| CING Cingulate | Initiates: Buy | $2,160 | $6.21 | +34,682.61% | 1 | Jan 11, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $120 | $1.57 | +7,543.31% | 1 | Dec 7, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $9 → $10 | $0.45 | +2,139.14% | 2 | Nov 1, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $60 → $56 | $31.39 | +78.40% | 2 | Sep 9, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $26 → $27 | $3.54 | +662.71% | 3 | Aug 17, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $40 → $35 | $0.92 | +3,717.21% | 4 | Jun 7, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $12 | $1.11 | +981.08% | 1 | Mar 22, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $75 | $24.02 | +212.24% | 1 | Jan 26, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $104 → $88 | $2.12 | +4,050.94% | 3 | Oct 19, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $180 | $0.57 | +31,396.06% | 1 | Oct 8, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $195 → $135 | $10.65 | +1,167.61% | 3 | Aug 3, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $14 | $6.39 | +119.09% | 1 | Jul 13, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $180 → $220 | $14.46 | +1,421.44% | 7 | May 4, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $8.5 | $2.58 | +229.46% | 1 | Mar 23, 2020 |
Evogene
Sep 12, 2022
Maintains: Buy
Price Target: $100 → $80
Current: $0.77
Upside: +10,289.61%
DarioHealth
Aug 18, 2022
Maintains: Buy
Price Target: $400 → $300
Current: $8.02
Upside: +3,640.65%
VolitionRx
Aug 15, 2022
Maintains: Buy
Price Target: $9 → $6
Current: $0.20
Upside: +2,870.30%
Immunic
Aug 8, 2022
Maintains: Buy
Price Target: $40 → $35
Current: $1.11
Upside: +3,053.15%
Stereotaxis
Jul 12, 2022
Initiates: Buy
Price Target: $6
Current: $1.84
Upside: +226.09%
Oramed Pharmaceuticals
May 16, 2022
Maintains: Buy
Price Target: $35 → $30
Current: $3.42
Upside: +777.19%
Trevi Therapeutics
Mar 29, 2022
Initiates: Buy
Price Target: $10
Current: $11.93
Upside: -16.18%
MediWound
Mar 21, 2022
Maintains: Buy
Price Target: $63 → $49
Current: $16.11
Upside: +204.16%
Enveric Biosciences
Mar 8, 2022
Downgrades: Hold
Price Target: $63,000 → $1,800
Current: $1.94
Upside: +92,683.51%
Cingulate
Jan 11, 2022
Initiates: Buy
Price Target: $2,160
Current: $6.21
Upside: +34,682.61%
Dec 7, 2021
Initiates: Buy
Price Target: $120
Current: $1.57
Upside: +7,543.31%
Nov 1, 2021
Maintains: Buy
Price Target: $9 → $10
Current: $0.45
Upside: +2,139.14%
Sep 9, 2021
Maintains: Buy
Price Target: $60 → $56
Current: $31.39
Upside: +78.40%
Aug 17, 2021
Maintains: Buy
Price Target: $26 → $27
Current: $3.54
Upside: +662.71%
Jun 7, 2021
Maintains: Buy
Price Target: $40 → $35
Current: $0.92
Upside: +3,717.21%
Mar 22, 2021
Initiates: Buy
Price Target: $12
Current: $1.11
Upside: +981.08%
Jan 26, 2021
Initiates: Buy
Price Target: $75
Current: $24.02
Upside: +212.24%
Oct 19, 2020
Maintains: Buy
Price Target: $104 → $88
Current: $2.12
Upside: +4,050.94%
Oct 8, 2020
Initiates: Buy
Price Target: $180
Current: $0.57
Upside: +31,396.06%
Aug 3, 2020
Maintains: Buy
Price Target: $195 → $135
Current: $10.65
Upside: +1,167.61%
Jul 13, 2020
Initiates: Buy
Price Target: $14
Current: $6.39
Upside: +119.09%
May 4, 2020
Maintains: Buy
Price Target: $180 → $220
Current: $14.46
Upside: +1,421.44%
Mar 23, 2020
Initiates: Buy
Price Target: $8.5
Current: $2.58
Upside: +229.46%